T Cell Lymphoma and Leukemia - Part 2 is organized by Opus Medicus, Inc.
Course Dates:
Last Review Date: 29-Jan-2024
Expiration Date: 28-Jan-2027
Description:
This course is part 2 of a 4 part series that summarizes, in concise clinicopathologic descriptions, each T cell entity with accompanying histology and immunohistology.
Objectives:
The objective of this series of courses is for participants to recognize the clinical findings, histopathology, immunophenotype, and genetic defects characteristic of each T cell leukemia and lymphoma subtype.
Topics:
Credits
AMA PRA Category 1 Credits™
Opus Medicus designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification (MOC) Credits
In addition to AMA PRA Category 1 Credits™, Opus Medicus designates this course for Specialty Board MOC Program Credits:
Accreditation Statement
Opus Medicus is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 CC/MOC credits for the American Board of Pathology (ABP) Continuing Certification (CC) / Maintenance of Certification (MOC) Program, in addition to AMA PRA Category 1 Credits™. Participants will earn CC/MOC credits equivalent to the amount of AMA PRA Category 1 credits claimed for the activity. Immediately upon course completion, Opus Medicus will submit participant completion information to ACCME for the purpose of granting ABP CC/MOC credit.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved